Marine Halbron

678 total citations
17 papers, 419 citations indexed

About

Marine Halbron is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and General Health Professions. According to data from OpenAlex, Marine Halbron has authored 17 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 5 papers in General Health Professions. Recurrent topics in Marine Halbron's work include Diabetes Management and Research (8 papers), Diabetes Management and Education (4 papers) and Diabetes and associated disorders (3 papers). Marine Halbron is often cited by papers focused on Diabetes Management and Research (8 papers), Diabetes Management and Education (4 papers) and Diabetes and associated disorders (3 papers). Marine Halbron collaborates with scholars based in France, Netherlands and Switzerland. Marine Halbron's co-authors include Vlad Ratziu, Éric Bruckert, Thierry Poynard, Gilles Lenaour, Philippe Giral, Frédéric Charlotte, Sophie Jacqueminet, André Grimaldi, Olivier Bourron and Agnès Hartemann–Heurtier and has published in prestigious journals such as The Lancet, PLoS ONE and Hepatology.

In The Last Decade

Marine Halbron

16 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marine Halbron France 9 295 215 113 80 73 17 419
Yanlan Fang China 6 271 0.9× 159 0.7× 96 0.8× 50 0.6× 59 0.8× 23 390
Antonio Luis Eiras de Araújo Brazil 6 403 1.4× 223 1.0× 67 0.6× 124 1.6× 87 1.2× 10 465
Masafumi Uno Japan 4 288 1.0× 147 0.7× 146 1.3× 81 1.0× 77 1.1× 6 410
Silvia Sabatini Italy 9 266 0.9× 140 0.7× 71 0.6× 61 0.8× 62 0.8× 18 416
Anna Bobrus‐Chociej Poland 9 224 0.8× 104 0.5× 96 0.8× 42 0.5× 63 0.9× 27 348
Eline H. van den Berg Netherlands 14 370 1.3× 230 1.1× 107 0.9× 121 1.5× 56 0.8× 23 515
Erika Paolini Italy 10 263 0.9× 101 0.5× 130 1.2× 78 1.0× 52 0.7× 27 407
Hiroshi Ishiba Japan 14 429 1.5× 266 1.2× 131 1.2× 149 1.9× 100 1.4× 18 560
Nadege Gunn United States 10 439 1.5× 188 0.9× 159 1.4× 210 2.6× 82 1.1× 21 583
Kyoko Yonemitsu Japan 6 296 1.0× 118 0.5× 95 0.8× 115 1.4× 88 1.2× 10 422

Countries citing papers authored by Marine Halbron

Since Specialization
Citations

This map shows the geographic impact of Marine Halbron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marine Halbron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marine Halbron more than expected).

Fields of papers citing papers by Marine Halbron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marine Halbron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marine Halbron. The network helps show where Marine Halbron may publish in the future.

Co-authorship network of co-authors of Marine Halbron

This figure shows the co-authorship network connecting the top 25 collaborators of Marine Halbron. A scholar is included among the top collaborators of Marine Halbron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marine Halbron. Marine Halbron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Salem, Joe‐Elie, Ziad A. Massy, Carole E. Aubert, et al.. (2020). Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes. PLoS ONE. 15(2). e0229145–e0229145. 10 indexed citations
2.
Amouyal, Chloé, David Klatzmann, Joe‐Elie Salem, et al.. (2020). Pregnant type 1 diabetes women with rises in C-peptide display higher levels of regulatory T cells: A pilot study. Diabetes & Metabolism. 47(3). 101188–101188. 5 indexed citations
3.
Roux, Énora Le, Marc Popelier, Marine Halbron, et al.. (2020). Transition of young adults with endocrine and metabolic diseases: the ‘TRANSEND’ cohort. Endocrine Connections. 10(1). 21–28. 12 indexed citations
4.
Melki, V., Lucy Chaillous, Michaël Joubert, et al.. (2020). m-santé et diabétologie : avancées en 2019. Médecine des Maladies Métaboliques. 14(2). 152–168. 1 indexed citations
5.
Halbron, Marine, Olivier Bourron, Fabrizio Andréelli, et al.. (2019). Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes. Diabetes Technology & Therapeutics. 21(7). 409–412. 12 indexed citations
6.
Aubert, Carole E., Sophie Liabeuf, Chloé Amouyal, et al.. (2019). Serum concentration and vascular expression of adiponectin are differentially associated with the diabetic calcifying peripheral arteriopathy. Diabetology & Metabolic Syndrome. 11(1). 32–32. 7 indexed citations
7.
Halbron, Marine, Jean Donadieu, Ahmed Idbaïh, et al.. (2019). Diabetes Mellitus, Extreme Insulin Resistance, and Hypothalamic-Pituitary Langerhans Cells Histiocytosis. Case Reports in Endocrinology. 2019. 1–8. 1 indexed citations
8.
Beltrand, Jacques, Létitia Pantalone, Pierre Chédin, et al.. (2018). Evaluation dâune stratégie standardisée de préparation à la transition chez les jeunes patients diabétiques en Ile de France : le programme PassâÃge.. 1 indexed citations
9.
Guillaume, A., et al.. (2017). m-santé francophone et diabète : avancées en 2017. Médecine des Maladies Métaboliques. 11(6). 530–536.
10.
Halbron, Marine, et al.. (2016). m-santé francophone et diabète : mise au point. Médecine des Maladies Métaboliques. 10(3). 243–253. 3 indexed citations
11.
Barnard, Katharine, Michael Bromba, Marine Halbron, et al.. (2015). High Reported Treatment Satisfaction in People With Type 1 Diabetes Switching to Latest Generation Insulin Pump Regardless of Previous Therapy. Journal of Diabetes Science and Technology. 9(2). 231–236. 9 indexed citations
12.
Bourron, Olivier, Martine Caron-Debarle, Zahir Amoura, et al.. (2014). Type B Insulin-resistance syndrome: a cause of reversible autoimmune hypoglycaemia. The Lancet. 384(9953). 1548–1548. 17 indexed citations
13.
Halbron, Marine, C. Sachon, D. Simon, et al.. (2013). Evaluation of a 5‐day education programme in Type 1 diabetes: achieving individual targets with a patient‐centred approach. Diabetic Medicine. 31(4). 500–503. 5 indexed citations
14.
Jacqueminet, Sophie, Olivier Barthélemy, François Rouzet, et al.. (2010). A randomized study comparing isotope and echocardiography stress testing in the screening of silent myocardial ischaemia in type 2 diabetic patients. Diabetes & Metabolism. 36(6). 463–469. 11 indexed citations
15.
Ratziu, Vlad, Frédéric Charlotte, Philippe Giral, et al.. (2009). Long-Term Efficacy of Rosiglitazone in Nonalcoholic Steatohepatitis: Results of the Fatty Liver Improvement by Rosiglitazone Therapy (Flirt 2) Extension Trial. Hepatology. 51(2). 445–453. 302 indexed citations
16.
Hartemann–Heurtier, Agnès, Marine Halbron, Jean‐Louis Golmard, et al.. (2009). Effects of bed-time insulin versus pioglitazone on abdominal fat accumulation, inflammation and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes Research and Clinical Practice. 86(1). 37–43. 15 indexed citations
17.
Halbron, Marine, Sophie Jacqueminet, C. Sachon, et al.. (2007). Insulin therapy for type 2 diabetes: premixed or basal-prandial?. Diabetes & Metabolism. 33(4). 316–320. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanlan Fang Breakdown of academic impact, for papers by Antonio Luis Eiras de Araújo Breakdown of academic impact, for papers by Masafumi Uno Breakdown of academic impact, for papers by Silvia Sabatini Breakdown of academic impact, for papers by Anna Bobrus‐Chociej Breakdown of academic impact, for papers by Eline H. van den Berg Breakdown of academic impact, for papers by Erika Paolini Breakdown of academic impact, for papers by Hiroshi Ishiba Breakdown of academic impact, for papers by Nadege Gunn Breakdown of academic impact, for papers by Kyoko Yonemitsu
Rankless by CCL
2026